Third-quarter sales for Oridion Systems Ltd. (ORIDN) slipped 8.3 percent, but better times might be in the offing as sales of its capnography equipment rebounded to “normal levels” during the latter half of the quarter.
Patient Monitoring
Masimo’s Q3 sales rise but net income slides
Masimo Corp. reported third-quarter net income of $13.1 million on sales of $87.4 million:
Press Release
Masimo Reports Third Quarter 2009 Financial Results
Q3 2009 Highlights:
– Product revenues increased 14% to $75.1 million from $66.1 million in prior year
– Rainbow revenues increased approximately 100% to $6.0 million from $3.0 million in prior year
– Shipped 26,200 Masimo SET and Masimo Rainbow SET pulse oximetry units
Oridion still can’t shake the Physio-Control blues
Sometimes it’s the company you keep.
For Oridion, which has its U.S. base of operations in Needham, Mass., that company would be Physio-Control Inc., one of its distribution partners.
Oridion, which makes capnography monitors to measure the amount of CO2 in a patient’s breath, took a 72 percent hit to its bottom line during the first six months of 2009 due to continuing problems with the distributor.
Oridion sells many of its products through OEM and and private-label agreements with companies like Siemens and Philips Medical Systems.
Oridion inks linkage deal with Masimo
Oridion and Masimo inked a deal to develop connectivity between Oridion’s Capnostream 20 respiration monitor and Masimo’s remote patient monitoring system.
Oridion, which houses its U.S. headquarters in Needham, Mass., will jointly develop a two-way interface to allow Irvine, Calif.-based Masimo’s Patient SafetyNet system to retrieve, analyze, and display physiological data from Capnostream monitors.
Boston Scientific wins some latitude
Boston Scientific Corp. won CE Mark approval from the European Union for its for its Latitude Patient Management remote patient monitoring system.
The Natick devices giant said the system is designed to keep tabs on patients with implanted cardiac devices, logging data on the devices and the patients’ hearts, detecting clinical events and sending the information directly to physicians.
The product will be rolled out in a phased launch in Europe beginning this week. More than 130,000 patients are using the system in the United States, where it hit the market in 2006.
Intel, GE to unite in healthcare venture
Intel Corp. and General Electric Co. are about to jump into the healthcare pool together, the Wall Street Journal reported.
A press conference is slated for April 2 in New York, hosted by Intel CEO Paul Otellini and GE CEO Jeffrey Immelt, where the two are expected to announce their collaboration.
Intel, the microprocessing giant, isn’t involved in healthcare but has been working for years to build a business in the sector.
Aspect Medical Systems delays annual meeting, girds for proxy fight
Officials at Aspect Medical Systems Inc. are delaying the company’s annual meeting to prepare for a possible proxy fight against two of its largest stockholders.
Officials at the Norwood-based brain-monitoring equipment maker said they needed “sufficient time to consider the potential director candidates, and provide shareholders with adequate time to consider the Board’s nominees,” according to a filing with the federal Securities and Exchange Commission.
Covidien breathes a little easier
They’re breathing a little easier at Mansfield-based Covidien Ltd. after the federal Food and Drug Administration approved the medical devices giant’s newest pulse oximeter.
Covidien‘s OxiMax SPD alert system answers the rising demand for continuous pulse oximetry monitors, especially for patients on powerful pain medication, company officials said.
The device uses an algorithm to detect patterns of reduced oxygen saturation in patients’ blood, which can indicate that a ventilator is compromised.